Robinhood Markets, Inc.’s TransCode Therapeutics RNAZ Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAZ
Robinhood Markets, Inc.'s RNAZ Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in TransCode Therapeutics (RNAZ) in Q3 2026: 102 shares worth $168. The stake represents ﹤0.01% of the portfolio and ranks #1035 among its holdings.
13 funds tracked by Wall St. Rank hold RNAZ as of Q3 2026.
- Robinhood Markets, Inc. held 102 shares of TransCode Therapeutics worth $168 as of Q3 2026.
- TransCode Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
- TransCode Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1035 holding.
- 13 funds tracked by Wall St. Rank held TransCode Therapeutics as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.